BIOTECHNOLOGY Meaning

Follow
Listen to Article Listen to this article read aloud

Audio uses the voice available in your browser or device.

History of biotechnology

People have been harnessing biological processes to improve their quality of lifef or some 10,000 years, beginning with thef irst agricultural communities.

 

 

 

A pproximately 6,000 years ago, humansb egan to tap the biological processes ofm icroorganisms in order to make bread,a lcoholic beverages, and cheese and top reserve dairy products. But such processes

are not what is meant today by biotechnology, a term first widely applied tot he molecular and cellular technologies thatb egan to emerge in the 1960s and ’70s. Af ledgling “biotech” industry began toc oalesce in the mid- to late 1970s, led by

Genentech , a pharmaceutical companye stablished in 1976 by Robert A. Swansona nd Herbert W. Boyer to commercialize ther ecombinant DNA technology pioneered byB oyer,

 

 

 

Paul Berg , and Stanley N. Cohen.E arly companies such as Genentech,A mgen, Biogen, Cetus, and Genex began bym anufacturing genetically engineered

substances primarily for medical and

environmental uses.F or more than a decade, the biotechnologyi ndustry was dominated by recombinant

 

 

DNA technology, or genetic engineering .T his technique consists of splicing the genef or a useful protein (often a human protein)

into production cells—such as yeast,

bacteria , or mammalian cells in culture—which then begin to produce the protein inv olume. In the process of splicing a gene into a production cell , a new organism is created. At first, biotechnology investors and researchers were uncertain about

whether the courts would permit them to acquire patents on organisms; after all,p atents were not allowed on new organisms that happened to be discovered and identified in nature. But, in 1980, the

U.S. Supreme Court , in the case of Diamond v. Chakrabarty , resolved the matter by ruling that “a live human-made microorganism is patentable subject matter.” This decision spawned a wave of new biotechnology firms and the infant

industry’s first investment boom. In 1982 recombinant insulin became the first product made through genetic engineering to secure approval from the U.S. Food and Drug Administration (FDA).

 

Since then, dozens of genetically engineered protein medications have been commercialized around the world, including recombinant versions of growth hormone , clotting factors, proteins for stimulating the production of red and white blood cells, interferons, and clot-dissolving agents.

Support the Writer

Enjoyed this article? You can support the writer with a voluntary donation.

Your donation supports Mustapha Muhammad Zango

Minimum donation: $2.00   •   70% of the donation is allocated to the writer after the LodPost commission.

Donate by Nigerian Bank Transfer

Send your donation in Nigerian Naira (₦). Your receipt will be reviewed by the LodPost admin before your donation is credited.

₦
Minimum donation: ₦100.00

How it works: Transfer the donation to the account above, upload your payment receipt, and our admin will verify and credit the writer.

Comments

You must be logged in to post a comment.

About Author

Member Since: Jan 01, 2022 Nigeria
0 Followers
0 Following
1 Articles
0 Likes
Related Articles